V020-2065 Screening compound: N,N-diethyl-3-({5-[(2-methylphenyl)methyl]-4-oxo-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepin-2-yl}formamido)propanamide

V020-2065 Screening compound: N,N-diethyl-3-({5-[(2-methylphenyl)methyl]-4-oxo-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepin-2-yl}formamido)propanamide
V020-2065 Screening compound: N,N-diethyl-3-({5-[(2-methylphenyl)methyl]-4-oxo-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepin-2-yl}formamido)propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V020-2065
N,N-diethyl-3-({5-[(2-methylphenyl)methyl]-4-oxo-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepin-2-yl}formamido)propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V020-2065

Molecular Formula

C23H31N5O3 (C23 H31 N5 O3)

Compound Name

N,N-diethyl-3-({5-[(2-methylphenyl)methyl]-4-oxo-4H,5H,6H,7H,8H-pyrazolo[1,5-a][1,4]diazepin-2-yl}formamido)propanamide

IUPAC name

NN-diethyl-3-({5-[(2-methylphenyl)methyl]-4-oxo-4H5H6H7H8H-pyrazolo[15-a][14]diazepin-2-yl}formamido)propanamide

SMILES

CCN(CC)C(CCNC(c1nn(CCCN(Cc2c(C)cccc2)C2=O)c2c1)=O)=O

InChI

InChI=1S/C23H31N5O3/c1-4-26(5-2)21(29)11-12-24-22(30)19-15-20-23(31)27(13-8-14-28(20)25-19)16-18-10-7-6-9-17(18)3/h6-7,9-10,15H,4-5,8,11-14,16H2,1-3H3,(H,24,30)

InChI Key

QKLICFRZNBRUNT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19907653

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

425.53

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.849

Distribution Coefficient, logD

1.849

Water Solubility, LogSw

-2.39

Polar Surface Area

70.313

Acid Dissociation Constant (pKa)

13.50

Base Dissociation Constant (pKb)

5.88

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

47.80

V020-2065 in Drug Discovery

Included in Screening Libraries

Macl-GPIb alpha Interaction Library (22969 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular

References: we are preparing a list of scientific research reports with V020-2065 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V020-2065?
Check Price and Availability of V020-2065, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V020-2065 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V020-2065
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V020-2065
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V020-2065 available by request